Bruker (BRKR) is down -14.5%, or -$5.88 to $34.67.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker’s Q2 results reflect weak academic, biopharma demand, says Stifel
- Bruker reports preliminary Q2 EPS 32c-34c, consensus 43c
- Bruker price target lowered to $50 from $61 at BofA
- NIH directs staff not to end any extra research projects for now, NY Times says
- Bruker’s Growth Potential Driven by Innovations and Strategic Cost Management